BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 74857)

  • 1. Malignant hepatoma with disappearance of alpha-fetoproteinaemia after hemihepatectomy: a case report.
    Blumsohn D; Dajie SK; Prajapat DK
    S Afr Med J; 1977 Oct; 52(18):738. PubMed ID: 74857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
    Cristani A; Cioni G; De Santis M; Chianese L; Gozzetti G; Ventura E
    Hepatogastroenterology; 1994 Apr; 41(2):137-9. PubMed ID: 7520014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
    Ezaki T; Yukaya H; Ogawa Y; Chang YC; Nagasue N
    Cancer; 1988 May; 61(9):1880-3. PubMed ID: 2451558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer.
    Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J
    Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.
    Xia Y; Yan ZL; Xi T; Wang K; Li J; Shi LH; Wu MC; Shen F
    Hepatogastroenterology; 2012 Oct; 59(119):2248-54. PubMed ID: 22366528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
    Chang YC; Dai YC; Chow NH
    Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre and postoperative changes of alpha-fetoprotein and human chorionic gonadotropin in hepatoma of children.
    Ikeda K; Kimura N; Suita S; Hayashida Y; Nakagawara A; Kawaoi A
    Z Kinderchir; 1981 Sep; 34(1):42-55. PubMed ID: 6171944
    [No Abstract]   [Full Text] [Related]  

  • 10. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
    Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
    Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
    Polterauer P; Horak W; Legenstein E; Müller M
    Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of surgical resection for hepatocellular carcinoma.
    Choi TK; Edward CS; Fan ST; Francis PT; Wong J
    Hepatogastroenterology; 1990 Apr; 37(2):172-5. PubMed ID: 1692802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2012 May; 59(115):840-3. PubMed ID: 22469729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma detected by elevated levels of alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma in a patient with Budd-Chiari syndrome.
    Yamamoto M; Otsubo T; Ariizumi S; Nakano M; Takasaki K
    Int Surg; 2005; 90(2):81-4. PubMed ID: 16119710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
    J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A; Hajiro K; Takakuwa H; Kobashi Y
    Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular adenoma with a high level of alpha fetoprotein. Apropos of a case observed in the Central hospital of Yaoundé, Cameroon].
    Abolo Mbenti L; Misse M; Mbakop A; Ndam N; Andze ; Edzoa T; Malonga EE
    J Chir (Paris); 1992 Dec; 129(12):556-8. PubMed ID: 1284392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Kaneoka Y; Maeda A
    J Hepatol; 2012 Dec; 57(6):1251-7. PubMed ID: 22824818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
    Stajić M; Milosavljević J
    Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.